Editorial: Immune-checkpoint inhibitors in anti-cancer armamentarium: a double-edged sword in risk of developing autoimmunity and immune-related adverse effects

類似資料

• Management of immune checkpoint inhibitor‐related dermatologic adverse events
  著者:: Xiaoyan Si, 等
  出版事項: (2020-02-01)
• Rituximab for severe immune checkpoint inhibitor-related adverse events: a multicenter case series
  著者:: Stéphanie Hermabessiere, 等
  出版事項: (2026-02-01)
• Endocrine Adverse Events in Patients Treated with Immune Checkpoint Inhibitors: A Comprehensive Analysis
  著者:: Meriç Dökmetaş, 等
  出版事項: (2025-01-01)
• Safety of immune checkpoint inhibitor rechallenge after severe immune-related adverse events: a retrospective analysis
  著者:: Céline Eldani, 等
  出版事項: (2024-07-01)
• Immune-Related Adverse Events Predict the Efficacy of Immune Checkpoint Inhibitors in Lung Cancer Patients: A Meta-Analysis
  著者:: Donghui Wang, 等
  出版事項: (2021-03-01)